Varaico: Literature-Extracted Genetic Variants

Gene:SETD2
Variant:p.G597D
Back to variants list

SETD2

NM_014159.7:p.G597D

Associated Papers

Correlation between hypoxia-inducible factor-1α C1772T/G1790A polymorphisms and head and neck cancer risk: a meta-analysis.

Wu T et al.

World Journal of Surgical Oncology, 2021

A Functional Polymorphism in HIF-3α Is Related to an Increased Risk of Ischemic Stroke.

Gu XX et al.

Journal of Molecular Neuroscience : Mn, 2021

Single nucleotide polymorphisms and serologic levels of hypoxia-inducible factor1 α and vascular endothelial growth factor are associated with increased risk of oral submucous fibrosis in gutka users among a North Indian population.

Gupta SR et al.

Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 2020

Association of hypoxia-inducible factor-1 alpha gene polymorphism with renal cell carcinoma susceptibility.

Huang L et al.

Journal of Cancer Research and Therapeutics, 2018

Association of hypoxia inducible factor-1 alpha exon 12 mutation in diabetic patients with and without diabetic foot ulcer.

Pichu S et al.

International Journal of Biological Macromolecules, 2018

Polymorphisms in HIFs and breast cancer sutarsceptibility in Chinese women: a case-control study.

Shan C et al.

Bioscience Reports, 2018

HIF1A gene polymorphisms and human diseases: Graphical review of 97 association studies.

Gladek I et al.

Genes, Chromosomes & Cancer, 2017

Association Between HIF-1 Alpha Gene Polymorphisms and Response in Patients Undergoing Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer.

Chen Q et al.

Medical Science Monitor : International Medical Journal of Experimental and Clinical Research, 2016

Potential signaling pathway of hypoxia-inducible factor in lung cancer and its gene polymorphism with lung cancer risk.

Liao SH et al.

Journal of Receptor and Signal Transduction Research, 2015

Association between HIF-1α C1772T/G1790A polymorphisms and cancer susceptibility: an updated systematic review and meta-analysis based on 40 case-control studies.

Yan Q et al.

Bmc Cancer, 2014

HIF-1α genetic variants and protein expression confer the susceptibility and prognosis of gliomas.

Yi L et al.

Neuromolecular Medicine, 2014

Update meta-analysis on 1790G/A polymorphism and cancer risk: Evidence from 26 studies.

Liu P et al.

Neoplasma, 2014

HIF-1α polymorphism in the susceptibility of cervical spondylotic myelopathy and its outcome after anterior cervical corpectomy and fusion treatment.

Wang ZC et al.

Plos One, 2014

No association of hypoxia inducible factor-1α gene polymorphisms with breast cancer in North-West Indians.

Sharma S et al.

Asian Pacific Journal of Cancer Prevention : Apjcp, 2014

High HIF-1α expression genotypes in oral lichen planus.

de Carvalho Fraga CA et al.

Clinical Oral Investigations, 2013

Hypoxia-inducible factor-1α polymorphisms link to coronary artery collateral development and clinical presentation of coronary artery disease.

Liu Q et al.

Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia, 2013

Clinicopathological significance of hypoxia-inducible factor-1 alpha polymorphisms in cancers: evidence from a meta-analysis.

Hu X et al.

Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine, 2013

1790 G/A polymorphism, but not 1772 C/T polymorphism, is significantly associated with cancers: an update study.

Liu J et al.

Gene, 2013

Polymorphisms in HIF-1alpha affect presence of lymph node metastasis and can influence tumor size in squamous-cell carcinoma of the glottic larynx.

Mera-Menéndez F et al.

Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2013

An association study between hypoxia inducible factor-1alpha (HIF-1α) polymorphisms and osteonecrosis.

Chachami G et al.

Plos One, 2013

HIF-1α 1772 C/T and 1790 G/A polymorphisms are significantly associated with higher cancer risk: an updated meta-analysis from 34 case-control studies.

Yang X et al.

Plos One, 2013

HIF1α genetic variants and protein expressions determine the response to platinum based chemotherapy and clinical outcome in patients with advanced NSCLC.

Wu F et al.

Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology, 2013

Single nucleotide polymorphisms in the HIF-1α gene and chemoradiotherapy of locally advanced rectal cancer.

Havelund BM et al.

Oncology Letters, 2012

Association of hypoxia inducible factor-1α polymorphisms with susceptibility to non-small-cell lung cancer.

Kuo WH et al.

Translational Research : the Journal of Laboratory and Clinical Medicine, 2012

No association of the hypoxia-inducible factor-1α gene polymorphisms with survival in patients with colorectal cancer.

Lee SJ et al.

Medical Oncology (northwood, London, England), 2011

Polymorphisms in the hypoxia-inducible factor-1α gene confer susceptibility to pancreatic cancer.

Wang X et al.

Cancer Biology & Therapy, 2011

[Association of combined polymorphisms in MIP-1α and ApoE genes with the susceptibility of inflammatory bowel disease].

Liang WD et al.

Zhonghua Yi Xue Za Zhi, 2011

Polymorphisms in the hypoxia-inducible factor 1 alpha gene in Mexican patients with preeclampsia: A case-control study.

Nava-Salazar S et al.

Bmc Research Notes, 2011

Hypoxia-inducible factor 1α polymorphisms and early-stage cervical cancer.

Kim YH et al.

International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society, 2011

Association between the polymorphisms in exon 12 of hypoxia-inducible factor-1alpha and the clinicopathological features of oral squamous cell carcinoma.

Shieh TM et al.

Oral Oncology, 2010

Hypoxia inducible factor-1alpha gene polymorphism G1790A and its interaction with tobacco and alcohol consumptions increase susceptibility to hepatocellular carcinoma.

Hsiao PC et al.

Journal of Surgical Oncology, 2010

Association of hypoxia-inducible factor 1-alpha gene polymorphisms and colorectal cancer prognosis.

Szkandera J et al.

Anticancer Research, 2010

Hypoxia-inducible factor-1alpha gene polymorphisms and cancer risk: a meta-analysis.

Zhao T et al.

Journal of Experimental & Clinical Cancer Research : Cr, 2009

Association of the hypoxia inducible factor-1alpha gene polymorphisms with gastric cancer in Tibetans.

Li K et al.

Biochemical Genetics, 2009

Polymorphisms in the hypoxia inducible factor 1-alpha and the impact on the prognosis of early stages of oral cancer.

Muñoz-Guerra MF et al.

Annals of Surgical Oncology, 2009

Ethnic variability of HIF-1alpha polymorphisms.

Ribeiro AL et al.

Cancer Biomarkers : Section a of Disease Markers, 2009

The C1772T genetic polymorphism in human HIF-1alpha gene associates with expression of HIF-1alpha protein in breast cancer.

Kim HO et al.

Oncology Reports, 2008

[Association between polymorphisms of HIF-1alpha C1772T and G1790A and hypoxic acclimation in high altitude in Tibetans].

Liu K et al.

Sheng Wu Yi Xue Gong Cheng Xue Za Zhi = Journal of Biomedical Engineering = Shengwu Yixue Gongchengxue Zazhi, 2007

Association between ulcerative growth and hypoxia inducible factor-1alpha polymorphisms in colorectal cancer patients.

Fransén K et al.

Molecular Carcinogenesis, 2006

Hypoxia-inducible factor-1alpha polymorphisms associated with enhanced transactivation capacity, implying clinical significance.

Tanimoto K et al.

Carcinogenesis, 2003

Association of thymidylate synthase and hypoxia inducible factor-1alpha DNA polymorphisms with pancreatic cancer.

Ruiz-Tovar J et al.

Tumori, 0

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."